Keywords: Nε- (کربوکسی متیل) لیزین; AGE; Advanced glycation endproduct; CML; Nε-(carboxymethyl)lysine; CEL; Nε-(carboxyethyl)lysine; MG-H1; 5-hydro-5-methylimidazolone; MMP; Matrix metalloproteinase; TIMP; Tissue inhibitor of metalloproteinase; Type 1 diabetes; AGEs; MMPs; TIMP-1; Cardiov
مقالات ISI Nε- (کربوکسی متیل) لیزین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine in tea and the factors affecting their formation
Keywords: Nε- (کربوکسی متیل) لیزین; Nε-(carboxymethyl)lysine; Nε-(carboxyethyl)lysine; Tea; LC-MS/MS; Catechins;
Nε-(carboxymethyl)lysine Concentration in Debris from Carotid Artery Stenting Correlates Independently with Signal Intensity on T1-Weighted Black-Blood Magnetic Resonance Images
Keywords: Nε- (کربوکسی متیل) لیزین; Nε-(carboxymethyl)lysine; carotid artery stenting; debris; vulnerable plaque; myeloperoxidase; magnetic resonance imaging;
Phenolic compounds reduce formation of Nε-(carboxymethyl)lysine and pyrazines formed by Maillard reactions in a model bread system
Keywords: Nε- (کربوکسی متیل) لیزین; PC; phenolic compound; C; (+)-catechin; Q; quercetin; GA; gallic acid; FA; ferulic acid; CA; caffeic acid; CML; Nε-(carboxymethyl)lysine; AGEs; advanced glycation end-products; ε-DNP-lysine; Nε-(2:4-Dinitrophenyl)-l-lysine; HS-SPME; headspace solid pha
Na+/K+-ATPase interaction with methylglyoxal as reactive metabolic side product
Keywords: Nε- (کربوکسی متیل) لیزین; aa residue; amino acid residue; AMG; aminoguanidine, also pimagedine; Arg (R); arginine; ATP; adenosine triphosphate; BSA; bovine serum albumin; CHER; catalytic hydrogen evolution reaction; CML; Nε-(carboxymethyl)lysine; CPS; constant-current chronopoten
Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies
Keywords: Nε- (کربوکسی متیل) لیزین; Nε-(carboxymethyl)lysine; Oral acute toxicity; Subacute toxicity; Oxidative stress; Mice; CML; Nε-(carboxymethyl)lysine; AGEs; advanced glycation endproducts; OECD; Organization for Economic Co-operation and Development; LD50; median lethal dose; RBC; r
Nε-(Carboxymethyl)lysine in Debris from Carotid Artery Stenting: Multiple versus Nonmultiple Postoperative Lesions
Keywords: Nε- (کربوکسی متیل) لیزین; Carotid artery stenting; debris; Nε-(carboxymethyl)lysine; myeloperoxidase; new ischemic lesion;
Simultaneous analysis of Nε-(carboxymethyl)lysine, reducing sugars, and lysine during the dairy thermal process
Keywords: Nε- (کربوکسی متیل) لیزین; Maillard reaction; Nε-(carboxymethyl)lysine; high performance anion-exchange chromatography with pulsed amperometric electrochemical detection (HPAEC-PAD); advanced glycation end product;
Methylglyoxal-induced modification of arginine residues decreases the activity of NADPH-generating enzymes
Keywords: Nε- (کربوکسی متیل) لیزین; AGE; advanced glycation end-product; BN-PAGE; blue native polyacrylamide gel electrophoresis; BSA; bovine serum albumin; CEC; S-(carboxyethyl)cysteine; CEL; Nε-(carboxyethyl)lysine; CML; Nε-(carboxymethyl)lysine; G6P; glucose 6-phosphate; G6PD; glucose
Endogenous mitochondrial oxidative stress in MnSOD-deficient mouse embryonic fibroblasts promotes mitochondrial DNA glycation
Keywords: Nε- (کربوکسی متیل) لیزین; AGE; advanced glycation end-product; CEdG; N2-carboxyethyl-2â²-deoxyguanosine; CEL; Nε-(carboxyethyl)lysine; CML; Nε-(carboxymethyl)lysine; DNPH; 2,4-dinitrophenylhydrazine; MEF; mouse embryonic fibroblast; MnSOD; manganese superoxide dismutase; mtDNA;
Catalase, a target of glycation damage in rat liver mitochondria with aging
Keywords: Nε- (کربوکسی متیل) لیزین; AGE; advanced glycation endproduct; CML; Nε-(carboxymethyl)lysine; CEL; Nε-(carboxyethyl)lysine; GPx-1; glutathione peroxidase-1; MGO; methylglyoxal; MnSOD; superoxide dismutase-manganese; Prx-3; peroxiredoxin-3; ROS; reactive oxygen species; Aging; Gly
Research ArticleEndogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis
Keywords: Nε- (کربوکسی متیل) لیزین; NAFLD; nonalcoholic fatty liver disease; CML; Nε-(carboxymethyl)lysine; RAGE; receptor for advanced glycation endproducts; UPLC; ultra performance liquid chromatography; MS; mass spectrometry; ALAT; alanine aminotransferase; ASAT; aspartate aminotransfer
Characterization of the glycated human cerebrospinal fluid proteome
Keywords: Nε- (کربوکسی متیل) لیزین; AD; Alzheimer's disease; AGEs; Advanced glycation end products; ALS; Amyotrophic lateral sclerosis; BAC; Boronate affinity chromatography; β2M; Beta-2 microglobulin; CID; Collision-induced dissociation; CJD; Creutzfeld-Jakob disease; CML; Nε-(carboxym
Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats
Keywords: Nε- (کربوکسی متیل) لیزین; Advanced glycation end-product (AGEs); Nε-(carboxyethyl)lysine (CEL); Cataract; Diabetes; Ketosis; Nephropathy; AGEs; advanced glycation end-products; CEL; Nε-(carboxyethyl)lysine; CML; Nε-(carboxymethyl)lysine; INS; insulin; CA; citric acid;